Three-Year Follow-Up Of Neoadjuvant Chemotherapy With Or Without Anthracyclines In The Presence Of Dual Her2-Blockade For Her2-Positive Breast Cancer (Train-2): A Randomized Phase Iii Trial.

Anna van der Voort,Mette S. van Ramshorst,Erik D. van Werkhoven,Ingrid A. Mandjes,Inge Kemper,Annelie J. Vulink,Irma M. Oving,Aafke H. Honkoop,Lidwine W. Tick,Agnes J. van de Wouw,Caroline M. Mandigers,Laurence J. C. van Warmerdam,Jelle Wesseling,Marie-Jeanne T.F.D Vrancken Peeters,Sabine C. Linn,Gabe S. Sonke

JOURNAL OF CLINICAL ONCOLOGY（2020）

引用 35|浏览56

暂无评分

摘要

501Background: The multicenter phase III TRAIN-2 study showed high pathological complete response (pCR) rates after neoadjuvant chemotherapy with and without anthracylines plus dual HER2-blockade i...

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要